Michael Greiner - Mar 6, 2023 Form 4/A - Amendment Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role: SVP - Chief Financial Officer
Signature: /s/ Mojirade James, as attorney-in-fact for Michael C. Greiner
Stock symbol: AVNS
Transactions as of: Mar 6, 2023
Transactions value $: -$89,956
Form type: 4/A - Amendment
Date filed: 3/23/2023, 11:31 AM
Date Of Original Report: Mar 7, 2023
Previous filing: Jan 4, 2023
Next filing: May 9, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AVNS	Common Stock	Award	$0	+34.6K	+36.66%	$0.00	129K	Mar 6, 2023	Direct	F1, F2
transaction	AVNS	Common Stock	Tax liability	-$90K	-3.04K	-2.35%	$29.62	126K	Mar 6, 2023	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents time-based restricted share units awarded pursuant to the Issuer's 2021 Long Term Incentive Plan. The award will vest 1/3 on March 6, 2024, 1/3 on March 6, 2025 and 1/3 on March 6, 2026.
F2	Total beneficially owned includes 339 shares acquired on December 30, 2022 and 327 shares acquired on June 30, 2022 under the Issuer's Employee Stock Purchase Plan.
F3	Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of time-based restricted share units awarded to the Reporting Person on March 4, 2022, 1/3 of which vested on March 4, 2023, with the remainder vesting 1/3 on March 4, 2024 and 1/3 on March 4, 2025.

Remarks:

This Form 4/A is being filed to correct an error in the calculation of the number of time-based restricted share units issued to the Reporting Person on March 6, 2023 pursuant to the Issuer's 2021 Long Term Incentive Plan.